News

ICYMI: Dr. Clark breaks down the results of the PANORAMA Study

ICYMI: Dr. Singh shares the take-home message from his 2019 presentation

ICMYI: Dr. Wykoff discusses results from his ASRS presentation

ICYMI: Abicipar Phase II MAPLE Trial supports improved safety for patients with nAMD following a Modified Manufacturing Process

Despite cost, advantages include sensitivity, improved outcomes

This year’s ASRS PAT survey show subtle regional differences

 The ASRS Global Trends Survey finds differences in some treatment preferences

ICYMI: ASRS-developed program aims to support physicians with confidential comparisons